<DOC>
	<DOCNO>NCT00388791</DOCNO>
	<brief_summary>The purpose study compare efficacy Systane Free Saline decrease symptom dry eye aggressive therapy . As principal outcome measure , use modify Schein dry eye symptomatology questionaire determine whether improvement sign mirror improvement Schein Score . Up 30 dry eye subject dose six time per day one month . The typical clinical sign onmitored ( e.g. , corneal stain ) along dyrness symptom . The hypothesis optimize drop , Systane Free , effective saline solution improve dry eye sign symptom .</brief_summary>
	<brief_title>Comparison Systane Free vs. Saline Treatment Dry Eye</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<criteria>The informed consent document must read , sign date subject legally authorize representative conducting procedure . Additionally , informed consent document must sign date individual obtain consent subject . Adult subject mild moderate dry eye . Criteria diagnosis must include two three follow characteristic demonstrated Eligibility Visit : Composite symptom score great equal 7 Schein Questionnaire . Sodium Fluorescein ( NaFl ) Tear BreakUp Time le 7 second eye . Cumulative Sodium Fluorescein Corneal Staining great equal 4 eye 0 20 point scale . Rose Bengal corneal stain great 4 24 maximum 6 zone . Able willing follow study instruction . Subjects must best correct visual acuity twenty twenty five good eye . The informed consent document must read , sign date subject legally authorize representative conducting procedure . Additionally , informed consent document must sign date individual obtain consent subject . Adult subject mildtomoderate dry eye . Criteria diagnosis must include two three follow characteristic demonstrated Eligibility Visit Composite symptom score great equal 7 Schein Questionnaire . Sodium FluoresceinTear BreakUp Time le equal 7 second eye . Cumulative Sodium Fluorescein Corneal Staining great equal 4 eye 0 20 point scale . Rose Bengal corneal stain great 4 24 maximum 6 zone . Able willing follow study instruction . Subjects must best correct visual acuity twenty twenty five good eye . History evidence ocular intraocular surgery either eye within past six month . LASIK keratorefractive procedure patient may participate surgery earlier 12 month time begin study . History evidence serious ocular trauma either eye within past six month . History hypersensitivity component study medication . These include artificial tear diagnostic dye sodium fluorescein . History evidence epithelial herpes simplex keratitis ( dendritic keratitis ) ; vaccinia , active recent varicella , viral disease cornea and/or conjunctiva ; chronic bacterial disease cornea and/or conjunctiva and/or eyelid ; mycobacterial infection eye ; and/or fungal disease eye . Use topical ocular medication study period . Subjects use systemic steroid , immunosuppressive agent and/or anticholinergic ( e.g . cold allergy medication , tricyclic antidepressant ) treatment autoimmune connective tissue disease may enrol study stable dose regimen minimum 30 day prior Eligibility Visit . In addition , dose regimen must remain stable throughout 4week treatment period . Ocular condition active acute conjunctival infection iritis . Individuals unwilling discontinue contact lens wear seven day prior study throughout study . Participation investigational drug device study within 30 day enter study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>symptomatology</keyword>
	<keyword>Schein questionnaire</keyword>
	<keyword>fluoresceien stain</keyword>
</DOC>